Effective acne treatments remain elusive, Hopkins researchers find

April 18, 2001

After a half-century of looking at everything from Accutane to zinc, dermatologists still can't prove which acne treatments and drugs work best, a team at Johns Hopkins Children's Center finds after combing the scientific literature.

"One of the key questions for dermatologists has been, 'How should we be treating acne in any given case?'" says pediatrician and medical informatics specialist Harold Lehmann, M.D., Ph.D. "Here we are in the 21st century and we still don't have a clear answer to that question."

Lehmann and his co-authors document the dilemma in a so-called evidence report for the U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality (AHRQ). The reports are designed to give the public state-of-the-science information about important health topics.

AHRQ asked Hopkins to analyze the relevant scientific literature and identify the best drugs for treating acne and to determine the strength of acne research findings based on predetermined criteria. The team selected 250 English-language studies that compared 150 acne drugs to each other or to a placebo.

Each study was categorized and rated according to details of how the study was performed, including how patients' acne was assessed and if statistical significance was achieved in each experimental comparison. After rating all the studies, the research team found only 14 of the studies met their criteria for a high "level of evidence", while the other 236 studies were almost equally divided between middle and low levels of evidence based on the group's criteria. "Some of the medicines in the studies we looked at seemed to work quite well," Lehmann says. "But it was impossible to say which medicines were the best for a specific acne condition."

Lehmann suggests that a lack of research standards and a deficiency of studies comparing drugs directly to each other might be to blame for the lack of consensus on best acne therapies.

"Dermatologists know a lot about acne," Lehmann says. "But without standards and guidelines for dermatological research, it's extremely hard to compare one study to another and learn which treatments are best."

Lehmann will work with members of the American Association of Pediatrics and the American Dermatological Society in May to create research standards and guidelines dermatologists can follow to help build consensus on favored acne treatments.
-end-
Funding for the report was provided by the U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality. Other researchers contributing to the report were Johns Hopkins researchers John Andrews, M.D., Karen Robinson, M.Sc., Victoria Holloway M.D., M.P.H., Steven Goodman, M.D., Ph.D.

Media contact: David Bricker 410-955-223-1728
Email: dbricker@jhmi.edu

Johns Hopkins Medical Institutions' news releases are available on an EMBARGOED basis on EurekAlert at http://www.eurekalert.org, Newswise at http://www.newswise.com and from the Office of Communications and Public Affairs' direct e-mail news release service. To enroll, call 410-955-4288 or send e-mail to bsimpkins@jhmi.edu.

On a POST-EMBARGOED basis find them at http://www.hopkinsmedicine.org and Quadnet at http://www.quad-net.com

Johns Hopkins Medicine

Related Acne Articles from Brightsurf:

Trifarotene in moderate acne: No study data for the assessment of the added benefit
Trifarotene in moderate acne: no study data for the assessment of the added benefit.

It cures acne, afib, anxiety? CBD users think its real medicine, contrary to evidence
A new study published in JAMA Network Open finds that as many as 90 percent of CBD users think it's real medicine, taking CBD to treat nearly all medical conditions, including substance use withdrawal, atrial fibrillation, and erectile dysfunction, to name a few.

Fighting cardiovascular disease with acne drug
Researchers from the European Molecular Biology Laboratory (EMBL) in Heidelberg and Stanford University have found the cause of dilated cardiomyopathy - a leading cause of heart failure - and identified a potential treatment for it: a drug already used to treat acne.

Anatomy of an acne treatment
Sarecycline, a drug approved for use in the United States in 2018, is the first new antibiotic approved to treat acne in more than 40 years.

Probiotics may help treat acne
Acne is caused by chronic inflammation and is often treated with antibiotics.

Doctors urged to reconsider controversial acne drug
Acne treatment including the highly effective acne medication isotretinoin should be made more readily available despite reports of its association with depression and teen suicide, a study recommends.

Are there racial/ethnic disparities in treatment for acne?
Whether there are differences in treatment of acne by race/ethnicity, sex and type of insurance was the focus of this observational study that analyzed treatment and prescribing patterns for acne for nearly 30,000 patients.

Does blue light therapy help acne? Efficacy and evidence is lacking
Conclusions about the effectiveness of blue light therapy for acne are limited.

Daily consumption of sweets, cakes and unhealthy foods associated with acne, study reveals
The research, presented at the 28th EADV Congress in Madrid, evaluated the exposure to different worsening factors on acne more than 6,700 participants across six countries in North America, South America and Europe.

Teenage acne may be a natural, transient inflammatory state
Adolescent acne does not always result in a pathological condition; rather, it may be a natural, transient inflammatory state occurring when the maturing facial skin is exposed to new microbes and enhanced production of an oily substance called sebum.

Read More: Acne News and Acne Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.